| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |